Logo image
Trimethoprim-sulfamethoxazole for the treatment of carbapenem-resistant Enterobacteriaceae (CRE) infections
Journal article   Peer reviewed

Trimethoprim-sulfamethoxazole for the treatment of carbapenem-resistant Enterobacteriaceae (CRE) infections

Aiman Bandali and Tiffany E Bias
Infectious diseases (London, England), v 51(6), pp 456-458
Jun 2019
PMID: 30856042

Abstract

Adult Anti-Bacterial Agents - therapeutic use Carbapenem-Resistant Enterobacteriaceae - drug effects Enterobacteriaceae Infections - drug therapy Female Humans Male Middle Aged Retrospective Studies Trimethoprim, Sulfamethoxazole Drug Combination - therapeutic use

Metrics

7 Record Views
4 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas
Infectious Diseases
Logo image